

SS&C Technologies vs Guidewire
SS&C Technologies vs Guidewire: this page compares business models, financial performance, and market context to help readers understand how the two companies operate. The presentation remains neutral and accessible, focusing on context rather than recommendations. Educational content, not financial advice.
SS&C Technologies vs Guidewire: this page compares business models, financial performance, and market context to help readers understand how the two companies operate. The presentation remains neutral...
Why It's Moving

SS&C Scores Voss Capital Win and Dublin Expansion, Fueling Alternative Assets Momentum
- Voss Capital selected SS&C GlobeOp for full fund admin across two funds and SMAs, praising its portal tech for streamlining wires, NAV reviews, and investor reporting[4][5].
- New Dublin entity under MiFID license enhances pan-European wealth management, complementing GlobeOp growth and AI-driven efficiencies for international clients[5][6][8].
- Quarterly $0.27 per share dividend declared, payable December 15, underscores commitment to shareholders with a 1.3% yield and 32% payout ratio[2][3].

SS&C Scores Voss Capital Win and Dublin Expansion, Fueling Alternative Assets Momentum
- Voss Capital selected SS&C GlobeOp for full fund admin across two funds and SMAs, praising its portal tech for streamlining wires, NAV reviews, and investor reporting[4][5].
- New Dublin entity under MiFID license enhances pan-European wealth management, complementing GlobeOp growth and AI-driven efficiencies for international clients[5][6][8].
- Quarterly $0.27 per share dividend declared, payable December 15, underscores commitment to shareholders with a 1.3% yield and 32% payout ratio[2][3].
Which Baskets Do They Appear In?
Healthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHigh-Switching-Cost Traps
These companies provide solutions that become so essential to their customers' operations that leaving is practically impossible. Professional analysts have selected these stocks for their ability to generate reliable revenue thanks to the immense difficulty and expense customers face when considering alternatives.
Published: June 17, 2025
Explore BasketWhich Baskets Do They Appear In?
Healthcare's Efficiency Imperative
UnitedHealth Group's recent profit miss, driven by high medical costs, has triggered a major cost-cutting initiative across the company. This move signals a broader industry trend, creating an investment opportunity in companies that provide AI and technology solutions to help healthcare organizations improve efficiency and reduce operational expenses.
Published: July 30, 2025
Explore BasketHigh-Switching-Cost Traps
These companies provide solutions that become so essential to their customers' operations that leaving is practically impossible. Professional analysts have selected these stocks for their ability to generate reliable revenue thanks to the immense difficulty and expense customers face when considering alternatives.
Published: June 17, 2025
Explore BasketInvestment Analysis
Pros
- SS&C Technologies demonstrated strong Q3 2025 results with 7% revenue growth and 17% earnings per share growth, reflecting solid operational execution.
- The company has a diversified technology stack serving financial services and healthcare sectors, reducing dependency on any single market segment.
- Analyst consensus rates SS&C as a strong buy with a forward price target indicating potential upside from current levels.
Considerations
- SS&C's stock exhibits moderate volatility with a Beta of 1.23, indicating higher sensitivity to market swings compared to the broader market.
- While the company pays a dividend, the yield is relatively low at around 1.28%, limiting income appeal to dividend-focused investors.
- Recent short interest increased to over 30%, suggesting elevated bearish sentiment or hedging activity among some investors.

Guidewire
GWRE
Pros
- Guidewire Software benefits from a strong position in the insurance software market, supporting recurring revenue streams from its software platform.
- The companyβs growth prospects are driven by ongoing digital transformation trends and demand for cloud-based insurance solutions.
- Guidewire maintains a dedicated R&D focus, enhancing product innovation and long-term competitive advantage in a niche market.
Considerations
- Guidewire is currently considered significantly overvalued by analysts, trading at a large premium compared to intrinsic value estimates.
- The company faces execution risks linked to transitioning customers to cloud models, which can impact near-term margins and growth visibility.
- Macroeconomic uncertainty and competition from larger software vendors increasing pressure on pricing and customer acquisition.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Comparisons


SS&C Technologies vs onsemi
SS&C Technologies vs onsemi


SS&C Technologies vs Twilio
SS&C Technologies vs Twilio


Toast vs Guidewire
Toast vs Guidewire